Benzinga | May 6, 2021 04:45PM EDT

OptimizeRx Q1 EPS $0.03 Beats $0.01 Estimate, Sales $11.20M Beat $10.47M Estimate

OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $0.01 by 200 percent. This is a 150 percent increase over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $11.20 million which beat the analyst consensus estimate of $10.47 million by 6.97 percent. This is a 47.66 percent increase over sales of $7.58 million the same period last year.